Release Notes:
Data Element
Version 2018A
| Data Element Name: |
IV Thrombolytic Initiation |
|---|
| Collected For: |
ASR-IP-1, ASR-OP-1, ASR-OP-2, CSTK-05, STK-4 |
|---|
| Definition: | Intravenous (IV) thrombolytic therapy was initiated at this hospital. IV thrombolytics convert plasminogen to plasmin, which in turn breaks down fibrin and fibrinogen, thereby dissolving thrombus. IV t-PA is the only FDA-approved IV thrombolytic for stroke. |
|---|
| Suggested Data Collection Question: | Is there documentation that IV thrombolytic therapy was initiated at this hospital?
|
|---|
| Format: |
| Length: | 1 |
|---|
| Type: | Alphanumeric |
|---|
| Occurs: | 1 |
|---|
|
|---|
| Allowable Values: |
Y (Yes) IV thrombolytic was initiated at this hospital.
N (No) IV thrombolytic was not initiated at this hospital, OR unable to determine from medical record documentation.
|
|---|
| Notes for Abstraction: |
- When a “hang time” or “infusion time” for IV thrombolytic is documented in the medical record, select “Yes.”
- If IV thrombolytic therapy was administered at another hospital and patient was subsequently transferred to this hospital, select “No.”
- If the patient was transferred to this hospital with IV thrombolytic infusing, select “No.”
|
|---|
| Suggested Data Sources: |
- Emergency department record
- Progress notes
- IV flow sheets
- Medication records
|
|---|
| Additional Notes: |
|
|---|
| Guidelines for Abstraction: |
|---|
| Inclusion |
Exclusion |
Only Acceptable Thrombolytic Therapy for Stroke:
- Activase
- Alteplase
- IV t-PA
- Recombinant t-PA Tissue plasminogen activator
|
- Intra-arterial (IA) t-PA
- Thrombolytic administration to flush, open, or maintain patency of a central line, e.g., PICC line
|
|
IV Thrombolytic Initiation
Specifications Manual for Joint Commission National Quality Measures (v2018A)
Discharges 07-01-18 (3Q18) through 12-31-18 (4Q18)
^